Observational, Non-interventional Biomarker and Endotyping Study
Part of paid clinical trials in Urbana, Illinois.
- Sponsor
- Prenosis, Inc.
- Study ID
- NCT07675265
- Status
- Recruiting
Conditions
- ARDS (Acute Respiratory Distress Syndrome)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The goal of this observational study is to establish a centralized ARDS biorepository of longitudinal biospecimens and harmonized clinical data, develop unsupervised, therapy-agnostic endotyping algorithms, and develop unsupervised, therapy-specific treatment-prediction algorithms over a 24 month period.
Key Dates
- First listed
- Jun 30, 2026
- Start date
- Sep 14, 2026
- Status verified
- Sep 2026
- Primary completion
- Dec 31, 2028
- Completion
- Mar 31, 2029
Study Design
- Enrollment
- 1,200 participants (estimated)
Primary Outcome Measure
Number of Participants with an ARDS Diagnosis [ Time Frame: from enrollment to 28-day in-hospital mortality ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Carle Foundation Hospital | Urbana | Illinois | 61801 |
Find similar trials in Urbana, IL
By research site
Related Studies
- JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: BevacizumabPHASE2 · Recruiting · PPD Development, LP · Birmingham, Alabama
- JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: ParidiprubartPHASE2 · Recruiting · PPD Development, LP · Birmingham, Alabama
- JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: VilobelimabPHASE2 · Recruiting · PPD Development, LP · Birmingham, Alabama
- JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)PHASE2 · Recruiting · PPD Development, LP · Birmingham, Alabama